Top Page
Beamtree Holdings Ltd
(Sydney:BMT)
Beamtree Holdings Ltd (BMT) vs. iShares MSCI Australia ETF (EWA)
Beamtree Holdings Ltd Business Overview & Revenue Model
Beamtree Holdings Ltd Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.60M | 28.60M | 27.60M | 22.77M | 16.55M | 8.39M |
| Gross Profit | 4.91M | 28.60M | 4.89M | 2.14M | -202.00K | 2.77M |
| EBITDA | -4.68M | -808.00K | -331.00K | -1.26M | -2.28M | 1.02M |
| Net Income | -6.16M | -6.16M | -5.11M | -6.91M | -4.45M | -383.62K |
Balance Sheet | ||||||
| Total Assets | 54.29M | 54.29M | 59.65M | 62.53M | 63.91M | 47.05M |
| Cash, Cash Equivalents and Short-Term Investments | 4.78M | 4.78M | 5.04M | 8.81M | 6.35M | 14.12M |
| Total Debt | 3.26M | 3.26M | 1.66M | 755.00K | 1.12M | 799.36K |
| Total Liabilities | 12.36M | 12.36M | 12.52M | 15.31M | 15.33M | 4.96M |
| Stockholders Equity | 41.93M | 41.93M | 47.14M | 47.22M | 48.58M | 42.09M |
Cash Flow | ||||||
| Free Cash Flow | 440.00K | -1.84M | -4.51M | -1.88M | -4.83M | -2.64M |
| Operating Cash Flow | 609.00K | 609.00K | -492.00K | 768.00K | -2.32M | 240.65K |
| Investing Cash Flow | -2.45M | -2.45M | -4.02M | -2.65M | -5.16M | -2.98M |
| Financing Cash Flow | 1.58M | 1.58M | 749.00K | 4.34M | -286.00K | 12.65M |
Beamtree Holdings Ltd Technical Analysis
Beamtree Holdings Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | AU$126.24M | 78.33 | 1.89% | ― | 10.06% | ― | |
55 Neutral | AU$74.13M | -8.12 | -8647.54% | ― | 25.98% | 22.10% | |
52 Neutral | AU$23.25M | -12.89 | -17.05% | ― | 28.91% | -1050.00% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | AU$58.12M | -9.39 | -13.83% | ― | 3.61% | -17.03% | |
46 Neutral | AU$118.66M | ― | -12.35% | ― | 15.99% | 22.05% | |
40 Underperform | AU$16.45M | -0.24 | -240.60% | ― | -48.41% | -7200.00% |
Beamtree Holdings Ltd Corporate Events
Beamtree Holdings Limited has announced the approval of its amended Constitution following a special resolution by shareholders at the recent Annual General Meeting. This development signifies a strategic move that may impact the company’s governance structure and operational framework, potentially influencing its market positioning and stakeholder relations.
Beamtree Holdings Limited announced that all resolutions were passed by shareholders at their Annual General Meeting. This outcome reflects strong shareholder support and may positively influence the company’s strategic direction and governance, reinforcing its industry position and stakeholder confidence.
Beamtree Holdings Limited held its 2025 Annual General Meeting, highlighting significant innovations and strategic leadership appointments. The company announced the successful launch of its data analytics platform in Australia, with plans to expand into the UK market in early 2026 in partnership with the UK NHS Confederation. Additionally, Beamtree’s Picq Audit product has achieved strong market fit and is expanding from the public to the private sector and internationally, with revenue exceeding expectations.
Beamtree Holdings Limited has announced the appointment of Michelle Spiller as Chief Financial Officer and James Price as General Manager Sales for Australia and New Zealand. Michelle brings a wealth of experience in financial management and strategic planning from her previous roles in ASX-listed technology companies, while James has a strong background in health, aged care, and technology sectors. These appointments are expected to strengthen Beamtree’s executive team, enhance its operational and strategic priorities, and bolster its focus on core solutions and customer service in key markets.
Beamtree Holdings Limited has announced its Annual General Meeting (AGM) scheduled for November 27, 2025, in Sydney. The company has provided details on how shareholders can participate, either in person or virtually, and emphasized the importance of voting on resolutions. This announcement underscores Beamtree’s commitment to engaging with its shareholders and maintaining transparency in its operations.
Beamtree Holdings Ltd announced the cessation of 2,800,000 performance rights due to unmet conditions, as of October 10, 2025. This development may impact the company’s capital structure and could influence stakeholder perceptions regarding the company’s operational execution and strategic direction.
Beamtree Holdings Ltd has announced the issuance of 200,000 performance rights under an employee incentive scheme, which are not intended to be quoted on the ASX. This move is part of the company’s strategy to incentivize and retain talent, potentially impacting its operational efficiency and market competitiveness positively.
Beamtree Holdings Limited has announced a change in the director’s interest notice, specifically regarding Stuart McDonald. On October 15, 2025, McDonald acquired 200,000 fully paid ordinary shares at $0.23 per share through an on-market trade. This change reflects an increase in McDonald’s direct interest in the company, potentially indicating confidence in Beamtree Holdings’ future performance.
Beamtree Holdings Limited has announced the appointment of Stuart MacDonald as a director, effective from October 15, 2025. The announcement indicates that MacDonald currently holds no relevant interests in securities as either a registered holder or through contracts, suggesting a straightforward appointment without immediate financial implications for the company or its stakeholders.
Beamtree Holdings Limited reported a 9% increase in recurring revenue for Q1 FY26, driven by growth across all product lines, including a significant clinical coding audit contract in Singapore and new contracts for its PICQ Audit and Rippledown solutions. The company is advancing its strategic roadmap with international market expansions, including the deployment of an autonomous clinical coding solution and a collaboration with the NHS Confederation in the UK. The appointment of Stuart MacDonald as a Non-Executive Director is expected to aid in scaling Beamtree’s product offerings and international growth. Despite a reduction in cash reserves due to software investment, Beamtree remains confident in its ability to deliver continued financial improvement through disciplined cost management and strategic capital allocation.
Beamtree Holdings Ltd has announced the issuance of 39,104 ordinary fully paid shares under its Employee Incentive Plan, as part of salary contribution arrangements. This move reflects the company’s commitment to employee engagement and retention, potentially strengthening its operational capabilities and competitive positioning in the technology and healthcare data solutions market.
Beamtree Holdings Limited has announced that its Annual General Meeting will take place on November 27, 2025, in Sydney. The company has set October 16, 2025, as the deadline for director nominations. This meeting is a significant event for stakeholders as it provides an opportunity to discuss the company’s strategic direction and future initiatives, potentially impacting its operations and market positioning.